Clinical Trial Update: Physical Disability in Patients Treated With Betaferon

View source ↗

Summary

A Bayer-sponsored clinical trial assessing physical disability in patients treated with Betaferon for Multiple Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED